The association between anti‐insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast‐acting insulin aspart in children and adolescents with type 1 diabetes

BACKGROUND: Fast‐acting insulin aspart (faster aspart) is a novel formulation of insulin aspart (IAsp) ensuring ultrafast absorption and effect. AIM: To compare the pharmacokinetics between faster aspart and IAsp, based on free or total IAsp measurement, and investigate the association between anti‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Biester, Torben, von dem Berge, Thekla, Bendtsen, Line Quist, Bendtsen, Mette Dahl, Rathor, Naveen, Danne, Thomas, Haahr, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons A/S 2020
Materias:
Clinical Care and Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383777/
https://www.ncbi.nlm.nih.gov/pubmed/32306477
http://dx.doi.org/10.1111/pedi.13026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383777/
https://www.ncbi.nlm.nih.gov/pubmed/32306477
http://dx.doi.org/10.1111/pedi.13026

Ejemplares similares